As of 2026-09-18, the EV/EBITDA ratio of Accelerate Diagnostics Inc (AXDX) is -1.50. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. AXDX's latest enterprise value is 48.66 mil USD. AXDX's TTM EBITDA according to its financial statements is -32.50 mil USD. Dividing these 2 quantities gives us the above AXDX EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 13.5x - 16.0x | 14.3x |
| Forward P/E multiples | 17.9x - 20.6x | 18.9x |
| Fair Price | (76.60) - (69.10) | (71.39) |
| Upside | -225383.3% - -203329.0% | -210061.4% |
| Date | EV/EBITDA |